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Inflammation is an unspecific response of the immune system to pathogens, for example, 
invasion by bacteria. This thesis focuses on two aspects of inflammation in the context 
of bacterial infections: (1) mast cells and (2) mastitis. Mast cells are potent pro-
inflammatory leucocytes that have been implicated in the defence against bacterial 
infections. Mastitis is an inflammation of the mammary tissue and is one of the most 
economically destructive disease in the dairy industry worldwide. 
Here, mast cell synthesis of the potent pro-angiogenic vascular endothelial growth 
factor (VEGF) in response to stimuli with Staphylococcus aureus (S. aureus) was studied 
using an in vitro model of primary mouse mast cells. VEGF synthesis was found to be 
dependent on the presence of live whole bacteria.  
Previous in vivo investigations of the roles of mast cells in bacterial infections have 
been conducted using c-Kit-dependent mast cell-deficient mice. These mice suffer from 
numerous abnormalities in addition to the lack of mast cells. Instead, we used newer, c-
Kit-independent mast cell-deficient mice (Mcpt5-Cre), which have fewer non-mast cell 
related abnormalities. We found no impact of the mast cell deficiency on the course of 
intraperitoneal S. aureus infection (e.g., bacterial clearance and cytokine production). 
We differentiated the virulence of, and response to, a set of clinical bacterial strains 
of bovine mastitis origin. Escherichia coli (E. coli) and S. aureus strains were injected 
intraperitoneally into mice. One E. coli strain (strain 127) was found to consistently cause 
more severe infection (judged by a clinical score) and induce a distinct profile of 
cytokines (CXCL1, G-CSF, CCL2). The concentrations of these cytokines correlated 
with both the clinical score and bacterial burden. The kinetics of the clinical and 
molecular changes that occurred during acute bovine mastitis were studied using a bovine 
in vivo model in which mastitis was induced by an intramammary infusion of E. coli 
lipopolysaccharide. Changes in clinical parameters (clinical score, milk changes, rectal 
temperature) as well as in milk and plasma cytokine concentrations and changes in the 
metabolome were registered. The progression of these changes occurred in the following 
order: (1) signs of inflammation in the udder and an increase in milk cytokine 
concentrations (after/at two hours), (2) visible changes in the milk and an increase in 
milk somatic cell counts (SCCs) (four hours), (3) changes in the plasma metabolome 
(four hours) and (4) changes in the milk metabolome (24 hours). 
Keywords: mast cell, mastitis, inflammation, vascular endothelial growth factor 
Author’s address: Carl-Fredrik Johnzon, SLU, Department of Anatomy, Physiology and 
Biochemistry, P.O. Box 7011, 750 07 Uppsala, Sweden  
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Abstract 
  
  
  
Inflammation är ett ospecifikt immunsvar, exempelvis mot bakterier.  Denna 
avhandling fokuserar på två aspekter av inflammation i kontexten av bakterieinfektion: 
(1) mastceller och (2) mastit. Mastceller är potenta pro-inflammatoriska leukocyter som 
tros vara inblandande i försvaret mot bakterier. Mastit är en inflammation av 
mjölkkörtelvävnaden. 
Mastcellens syntes av den potenta pro-angiogenes faktorn vaskulär 
endotelcellstillväxtfaktor (VEGF) studerades i kontexten av Staphylococcus aureus (S. 
aureus) infektion. En in vitro modell baserad på primära musmastceller användes. Vi 
fann att mastcellens syntes av VEGF var beroende av närvaron av levande bakterier. 
Tidigare in vivo studier av mastcellens roll in bakterieinfektion har varit begränsade 
av deras beroende av c-Kit mastcellsdefekta möss. Dessa möss lider av flera fysiska 
defekter utöver frånvaron av mastceller. Vi använde oss av en ny musmodell där 
mastcellsdefekten induceras oberoende av c-Kit. I infektionsstudier med S. aureus fann 
vi att frånvaron av mastceller inte påverkade sjukdomsförloppet. 
En intraperitoneal musmodell användes för att studera och särskilja virulensen hos 
en selektion av bakteriestammar ursprungligen isolerade från kor med akut klinisk 
mastit. Möss infekterades med Escherichia coli (E. coli) och S. aureus genom 
intraperitoneal injektion. E. coli stammen 127 orsakade allvarligare infektioner 
(bedömdes med kliniskscore). Immunsvaret mot stammen genererade även en distinkt 
cytokinprofil (CXCL-1, G-CSF, CCL2). Koncentrationen av dessa cytokiner 
korrelerade mot både kliniskscore och antalet bakterier i bukhålan.  
Förändringar i kliniska och molekylära parametrar som sker i akut klinisk bovin 
mastit studerades med en bovin in vivo modell där mastit induceras med en 
intramammär E. coli lipopolysackarid infusion. Kliniska parametrar (kliniskscore, 
mjölkförändringar, temperatur), cytokinkoncentration i mjölk och plasma, och 
förändringar i metabolitkoncentrationer registrerades över tid. Vi fann att dessa 
förändringar skedde i följande ordning: (1) inflammatoriska tecken i juvret och ökade 
cytokinkoncentrationer i mjölken (två timmar), (2) synliga förändringar i mjölken och 
förhöjda somatiska cell antal i mjölken (SCCs) (fyra timmar), (3) förändringar i 
metabolitkoncentrationer i plasman (fyra timmar) och (4) förändringar i 
metabolitkoncentrationer i mjölken (24 timmar). 
Nyckelord: mastcell, mastit, inflammation, vaskulär endotelcellstillväxtfaktor 
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Sammafattning 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
I thought that I would begin this thesis with a whimsical little poem. It may have 
some bearing on the matter at hand. Thus: 
 
The cheese-mites asked how the cheese got there, 
And warmly debated the matter; 
The Orthodox said that it came from the air, 
And the Heretics said from the platter. 
They argued it long and they argued it strong, 
And I hear they are arguing now; 
But of all the choice spirits who lived in the cheese, 
Not one of them thought of a cow. 
 
A Parable (1898) 
Sir Arthur Conan Doyle 
  
Preface 
  
 
  
To my parents, and also to many dear friends and colleagues, whose sentiments 
on the passage of time I decidedly do not share 
Things that just keep passing by – A boat with its sail up.  
People’s age. 
Spring. Summer. Autumn. Winter. 
Sei Shōnagon 
 
Cold-hearted waves are these; not the waves but the years pass over the waiting   
pine. 
Michitsuna no Haha 
 
Now like a traveller who has tried two ways in vain 
I stand perplexed where these sad seasons meet. 
Murasaki Shikibu 
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BMMC Bone marrow-derived mast cell  
BTSCC Bulk tank somatic cell counts  
CCL Chemokine (C-C motif) ligand  
CFU Colony-forming unit  
CTMC Connective tissue mast cell  
CXCL Chemokine (C-X-C motif) ligand  
DAMP Damage-associated molecular pattern  
DT Diphtheria toxin  
ELISA Enzyme-linked immunosorbent assay  
FcγR Fc-gamma (γ) receptor  
FcεR Fc-epsilon (ε) receptor  
GAG Glycosaminoglycan  
G-CSF Granulocyte colony-stimulating factor  
ICSCC Individual cow somatic cell counts  
IFN Interferon  
Ig Immunoglobulin  
IL Interleukin  
IMI Intramammary infection  
iNOS Nitric oxide synthase  
LPS Lipopolysaccharide  
LTA Lipoteichoic acid  
MCC Mast cell containing chymase (human)  
MCP Monocyte chemoattractant protein  
MCT Mast cell containing tryptase (human)  
MCTC Mast cell containing both tryptase and chymase (human)  
MEC Mammary epithelial cell  
MMC Mucosal mast cell  
mMCP Mouse mast cell protease  
Abbreviations 
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mTMT Mouse transmembrane tryptase  
NETs Neutrophil extracellular traps  
NFAT Nuclear factor of activated T-cells  
NF-κB Nuclear factor-κB  
NLR Nucleotide-binding oligomerisation domain (NOD)-like 
receptor  
 
NMR Nuclear magnetic resonance  
PAM3 Pam3CSK4  
PAMP Pathogen-associated molecular pattern  
PCMC Peritoneal cell-derived mast cell  
PGN Peptidoglycan  
PRR Pattern-recognition receptor  
ROS Reactive oxygen species  
SCC Somatic cell count  
SCF Stem cell factor  
SLB Swedish Friesian (cattle breed)  
SptP Salmonella typhimurium tyrosine phosphatase  
SRB  Swedish Red-and-White (cattle breed)  
TLR Toll-like receptor  
TNF Tumour necrosis factor  
VEGF Vascular endothelial growth factor  
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1.1 Bacteria & the Immune System 
Immunology is, to an extent, the study, on the one hand, of a system that is 
noticeable by our imperceptions of its effects on the body and, on the other hand, 
of the discomfort its activity causes during moments of stress. I find myself that 
it is easier to recall with precision instances of sickness than the much longer 
periods of healthy everyday activity. This is perhaps a natural consequence of 
the human condition. After all, the immune system is a complex network of 
tissues that are largely unseen by the unaided human eye, which react to 
exposure to organisms and particles so numerous and infinitesimal that it is 
difficult to comprehend their existence. With these ruminations on perspective 
in mind, I was reminded of a short article written by Sir Arthur Conan Doyle1 
on knowledge of the immune system and bacteria in the late 19th century, titled 
“Life and Death in the Blood” (Doyle, 1883). The opening passage of that article 
proceeds as follows: 
 
“Had a man the power of reducing himself to the size of less than the one-
thousandth part of an inch, and should he, while of this microscopic stature, 
convey himself through the coats of a living artery, how strange the sight that 
would meet his eye!” (Doyle, 1883). 
1.1.1 Bacterial Life 
Bacteria are prokaryotes, unicellular organisms that are structurally 
distinguished by a lack of internal membranes separating the genetic material or 
enzymatic machinery into isolated compartments (Stanier & Van Niel, 1962). 
                                                        
1. Then simply Arthur Conan Doyle 
1 Introduction 
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They are morphologically and metabolically highly diverse organisms (Salton 
& Kim, 1996; Jurtshuk, 1996). Consequently, bacteria are present in a diverse 
set of environments, ranging from seawater to soil to the digestive systems of 
metazoans (Foster et al., 2017). 
1.1.2 The Immune System 
Animals, specifically mammals within the context of this thesis, are constantly 
exposed to a multitude of bacterial organisms2. From birth until death, the 
totality of a mammalian body represents fertile territory for these organisms to 
colonise. Indeed, they are found in virtually every surface or space available 
(Foster et al., 2017). It is the function of the immune system to protect the ‘self’ 
against these visitors. Interactions between the host and bacteria are not 
exclusively antagonistic. Indeed, the host is continuously exposed to and 
colonised by microbes – comprising the ‘microflora’ – without eliciting any 
negative effects. The mechanisms of these seemingly paradoxical interactions 
are the focus of a great deal of research (Chu & Mazmanian, 2013). The 
antagonistic interactions are the topic of this thesis. 
The immune system is broadly divided into an innate component and an 
adaptive component. These components are distinguished by the speed and 
specificity of their response. The innate response is immediate, whereas the 
adaptive response is specific but slow (days to weeks). The innate and adaptive 
immune systems, though composed of different cells, are not two entirely 
separate entities, and a fully functional immune system requires extensive 
interactions between the two (Crozat, Vivier & Dalod, 2009). 
Innate. The innate immune system is composed of anatomical barriers (e.g., 
the skin, mucosal surfaces), the complement system, a number of different 
leucocytes (neutrophils, monocytes, macrophages, natural killer cells, mast 
cells) and various molecular immune mediators (cytokines, acute-phase 
proteins). It is capable of separating “self” from “non-self” and is the first 
defence that a microorganism will encounter when it enters the body (Parkin & 
Cohen, 2001). 
Adaptive. The basis of the adaptive immune response are the T cells and B 
cells. T cells participate in cell-mediated mechanisms. B cells participate in 
immunoglobulin/antibody mediated responses (IgM, IgG, IgA, IgE, IgD). This 
is a stronger and more selective immunological response (i.e., it can distinguish 
between one species of bacteria and another and selectively react to one but not 
the other). This response is also characterised by immunological memory, which 
                                                        
2. To the bacteria, one must add the yeasts, moulds, protozoans, parasites and viruses 
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enables a more rapid response against a foreign particle upon subsequent re-
exposure (Parkin & Cohen, 2001).  
1.1.3 Inflammation 
Inflammation is an unspecific response of the immune system to pathogens or 
trauma, which is activated within minutes of exposure. It has two purposes: (1) 
defend the host against infection and (2) facilitate tissue-repair (Medzhitov, 
2008). In the context of this thesis, it is the former role, in relation to bacterial 
infections, which is relevant. 
Inflammation develops in vascularised tissues and is characterised by 
increased capillary permeability, vascular dilation, leucocyte infiltration and 
accumulation, and increased blood flow (Freire & Van Dyke, 2013; Ashley, 
Weil & Nelson, 2012). These effects culminate in the elimination or isolation of 
the invading bacteria. However, the unspecific nature of these effects does not 
distinguish between self and the bacteria, causing collateral damage to the 
affected tissue. Hence, the inflammatory response represents both a cost and an, 
albeit short-term, benefit to the host. The immediate noticeable effects of 
inflammation are concisely summarised by its five cardinal signs: calor (heat), 
dolor (pain), rubor (redness), tumor (swelling) and functio laesa (loss of 
function) (Ashley, Weil & Nelson, 2012). Unsurprisingly for such a distinct and 
visible activity of the body, references to inflammation are present in historical 
records dating as far back as ancient Egypt and ancient Mesopotamia (Ryan & 
Majno, 1977; Granger & Senchenkova, 2010). 
Inflammation from Activation to Resolution in Bacterial Infection 
The events of the inflammatory cascade are broadly divided into: Detection, 
Signalling, Response, Infiltration and Resolution. 
Detection. Inflammation is induced by the introduction of bacterial 
components into a tissue. These components take the form of either pathogen-
associated molecular patterns (PAMPs), which are produced by all bacteria, and 
virulence factors, which are restricted to pathogenic bacteria (Medzhitov, 2008). 
PAMPs are conserved molecular structures that are structurally distinct from 
self-molecules (Kumar, Kawai & Akira, 2011). They are detected by a 
corresponding set of host germline-encoded proteins called pattern-recognition 
receptors (PRRs) expressed primarily on immune cells (e.g., tissue resident 
macrophages). There are several different classes of PRRs. Two major receptor 
classes that detect bacterial PAMPs are the Toll-like receptors (TLRs), which 
are located on the plasma membrane and intracellular membranes, and the NOD-
like receptors (NLRs), which are located intracellularly (Takeuchi & Akira, 
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2010). In contrast, virulence factors trigger an inflammatory response through 
their effects on the host cells (e.g., pore formation) or direct tissue damage rather 
than through a set of conserved dedicated receptors that bind to specific foreign 
ligands (Medzhitov, 2008). In the latter case, the inflammatory response is 
activated by the detection of damage-associated molecular patterns (DAMPs). 
These are endogenous molecular structures that are not normally present in intact 
tissues. DAMPs are, like PAMPs, detected by PRRs (Sharma & Naidu, 2016). 
Signalling. The intracellular mechanism that will be initiated is determined 
by the identity of the activated receptor. TLRs commonly activate a signalling 
pathway that is dependent on the adaptor protein MyD88. The MyD88 pathway 
terminates with activation and translocation into the nucleus of the transcription 
factor nuclear factor-κB (NF-κB). Once in the nucleus, NF-κB upregulates the 
expression of pro-inflammatory genes. Signalling by NLRs leads to assembly of 
the inflammasome (an intracellular protein complex) that associates with and 
activates the enzyme caspase-1, which in turn activates inactive immune 
compounds by proteolytic cleavage (Ashley, Weil & Nelson, 2012; Sharma & 
Naidu, 2016). The inflammasome can also be activated by an efflux of K+ 
resulting from pore formation, an example of activation in response to a pore-
forming virulence factor (Mariathasan et al., 2006). 
Response. Inflammation is mediated by a large number of compounds 
divided into seven distinct categories: (1) cytokines, (2) chemokines, (3) 
eicosanoids, (4) proteolytic enzymes, (5) complement components, (6) 
vasoactive amines and (7) vasoactive peptides (Medzhitov, 2008).  
Cytokines and chemokines are small soluble signalling proteins. Cytokines 
such as interleukin (IL)-6 and tumour necrosis factor (TNF)-α enhance the 
activity of leucocytes, whereas chemokines, for example the neutrophil 
attractant IL-8, promote leucocyte chemotaxis (migration towards an increasing 
concentration of a chemoattractant) (Turner et al., 2014). Eicosanoids are a class 
of lipid-derived mediators that are synthesised enzymatically from 
phospholipids present on the plasma membrane. They include prostaglandins, 
thromboxanes and leukotrienes. These substances are, for example, involved in 
vasodilation (Dennis & Norris, 2015). Proteolytic enzymes promote 
inflammation through degradation of the extracellular matrix and promotion of 
leucocyte migration (Sharony et al., 2010). The complement system promotes 
inflammation by enhancing leucocyte migration (Parkin & Cohen, 2001). The 
vasoactive amines histamine and serotonin, increase vascular permeability and 
vasodilation (Barnes, 2001). Vasoactive peptides promote vascular permeability 
and vasodilation either directly or by inducing the release of vasoactive amines 
from immune cells (Medzhitov, 2008). The cumulative effect of all these 
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different compounds is the facilitation of leucocyte recruitment into the 
disturbed tissue. 
Infiltration. Neutrophils and monocytes migrate into the disturbed tissue 
from the blood through chemotaxis and extravasation (movement from the 
capillaries into the surrounding tissue) (Ashley, Weil & Nelson, 2012). 
Neutrophils kill bacteria through one of three mechanisms. First, they can engulf 
a bacterial cell by phagocytosis and kill it internally using reactive oxygen 
species (ROS). Second, they can degranulate and release antibacterial proteases 
as well as toxic chemicals including ROS. Third, they can trap bacteria using so-
called neutrophil extracellular traps (NETs). NETs are composed of core DNA 
elements together with various antimicrobial compounds (Kolaczkowska & 
Kubes, 2013). It is the release of toxic chemicals into the extracellular 
environment by neutrophils that is a major contributor to the damage that 
inflammation causes to the host tissue (Ashley, Weil & Nelson, 2012). 
Monocytes differentiate into macrophages inside inflamed tissue (Geissmann et 
al., 2010), where they proceed to phagocytose and destroy bacteria. They also 
promote inflammation through the synthesis and release of many pro-
inflammatory compounds (Zhang & Wang, 2014). 
Resolution. Resolution of inflammation is important to prevent extensive 
damage to the host tissue and to promote healing. It is dependent on a number 
of interlinked processes which aim to (1) deplete the supply of neutrophil 
chemoattractants in the tissue, (2) ensure neutrophil apoptosis, (3) clear away 
apoptotic neutrophils by macrophages, and (4) switch the phenotype of the 
macrophages from a pro-inflammatory to a pro-resolution phenotype. These pro-
resolution processes are driven by proteases, ROS, cytokines and other factors. 
The pro-resolution phenotype macrophages synthesise and release the pro-
resolution lipid-derived mediator lipoxin and the fatty acid-derived resolvins and 
protectins. These block further neutrophil recruitment and promote neutrophil 
apoptosis. The tissue returns to homeostasis and functionality by the combined 
actions of macrophages, stem cells and progenitor cells (Ashley, Weil & Nelson, 
2012; Ortega-Gómez, Perretti & Soehnlein, 2013). 
1.2 The Mast Cell 
1.2.1 A Brief History of the Mast Cell 
The mast cell has a long evolutionary history. Mast cells are found in all classes 
of vertebrates, and mast cell-like cells are present in some invertebrate classes 
(Crivellato & Ribatti, 2010). The mast cell was originally described by the 
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German biologist Paul Ehrlich in 1878. He named these cells “Mastzelle” (from 
the German “mast”, meaning “fattening”3). The name reflects Paul Ehrlich’s 
belief of a nutritional role for his newly described cell type (Crivellato et al., 
2003). Subsequent researchers with a wider array of tools at their disposal than 
the light microscope and dyes with which Ehrlich’s conducted his investigations, 
have classified the mast cell as a potent pro-inflammatory leucocyte with a range 
of putative functions, implicating it in many different pathologies. To date, the 
only truly well-established activity attributed to the mast cell is its involvement 
in IgE-mediated hypersensitivity (allergy) (Crivellato et al., 2003; Beaven, 
2009; Rodewald & Feyerabend, 2012). 
1.2.2 Introduction to the Mast Cell 
Mast cells are tissue-resident granulocytes (i.e., leucocytes containing 
cytoplasmic granules). They are distributed throughout the body but are 
particularly numerous in tissues that are directly exposed to the external 
environment (Marshall, 2004). Mast cells originate from bone marrow-derived 
pluripotent stem cell. Unlike other haematopoietic cells, mast cells circulate as 
immature progenitors and will only undergo the final steps in the maturation 
process once they enter a tissue (Dahlin & Hallgren, 2015). Morphologically and 
biochemically, mast cells are characterised by: (1) cytoplasmic secretory 
granules, (2) biogenic amines, (3) proteases, (4) proteoglycans, and (5) receptors 
for IgE. 
Granules. Mast cell secretory granules – also called secretory lysosomes – 
are membrane enclosed cytoplasmic particles and act as storage units for a wide 
range of compounds. Biogenic amines, proteases and proteoglycans are major 
granule compound classes. Additionally, some cytokines have been found in 
mast cell granules – e.g., TNF-α (Gordon & Galli, 1990: Wernersson & Pejler, 
2014). Up to 50 – 55% of the cytoplasmic space inside a mast cell is occupied 
by these granules (Yong, 1997). 
Biogenic Amines. Biogenic amines are synthesised from amino acids and 
have a wide range of effects when released into the extracellular milieu (Barnes, 
2001). The biogenic amines synthesised by mast cells are histamine, serotonin 
and dopamine (Barnes, 2001; Freeman et al., 2001). Histamine in particular is 
associated with mast cells, which constitute a major source of that amine. 
Histamine has different effects depending on the exposed cell type and the 
histamine receptors expressed by those cells (H1 – H4) (Barnes, 2001; Parsons & 
Ganellin, 2006). 
                                                        
3. With regards to the foci of this thesis, it is interesting to note that the word ”mast” derives 
from the Greek μαστόσ, meaning breast 
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Proteases. Mast cells synthesise two categories of proteases: (1) mast cell-
specific proteases and (2) proteases that are not exclusively found in mast cells 
(Wernersson & Pejler, 2014). Mast cell proteases are distinguished by their high 
level of expression, which may account for more than 25% of the total mast cell 
protein content, and that they are stored in their active form. Mast cells express 
three classes of cell-specific proteases: tryptase, chymase and carboxypeptidase 
A3 (Pejler et al., 2010). Tryptases are homotetrameric serine proteases with 
trypsin-like specificity (cleave after lysine/arginine residues). Human mast cells 
contain αI-, αII-, βI-, βII- and βIII-tryptase (Pallaoro et al., 1999). Mouse mast 
cells express four tryptases: transmembrane tryptase (mTMT), mouse mast cell 
protease (mMCP)-6, mMCP-7 and mMCP-11 (Pejler et al., 2007). Chymases 
are serine proteases. They are monomeric and have a chymotrypsin-like 
specificity (they cleave after aromatic amino acids). Chymases are divided into 
α- and β-chymases. Human mast cells only express one α-chymase. Mice 
express several chymases: the α-chymase mMCP-5 and the β-chymases mMCP-
1, mMCP-2 and mMCP-4 (Pejler et al., 2007). Carboxypeptidases are 
monomeric zinc-dependent metalloproteases that cleave after aromatic amino 
acids (Pejler et al., 2010). Unlike the other proteases, human and mouse mast 
cells only express one carboxypeptidase each (Pejler et al., 2007). Mast cell 
proteases have been attributed a wide range of physiological activities, including 
the recruitment of leucocytes, arthritis, the maintenance of tissue homeostasis 
and the degradation of toxins (Tchougounova et al., 2005; Metz et al., 2006; 
Schneider et al., 2007; Thakurdas et al., 2007; Shin et al., 2009). Non-mast cell-
restricted proteases found in granules include cathepsins and granzyme B, 
amongst several others (Wernersson & Pejler, 2014). 
Proteoglycans. Proteoglycans are glycoproteins composed of a protein core 
with numerous glycosaminoglycans (GAG) attached covalently as side chains. 
In mast cells, the dominant core protein is serglycin (Åbrink, Grujic & Pejler, 
2004). Serglycin contains lengthy regions of repeated serine and glycine 
residues. The length of these regions varies from species to species, but in mice 
and humans they are 18 – 21 aa long. These regions act as attachment sites for 
GAGs (Rönnberg, Melo & Pejler, 2012), polysaccharides composed of repeating 
sulphated disaccharide units. Due to the high degree of sulphation, 
proteoglycans are highly anionic. Mast cells synthesise GAGs of the heparin and 
chondroitin sulphate types. Proteoglycans have an essential role in the regulation 
of storage inside the granules. Serglycin-deficient mast cells show defective 
storage of proteases and biogenic amines (Åbrink, Grujic & Pejler, 2004; 
Ringvall et al., 2008). It seems paradoxical that mast cells store large amounts 
of proteases and proteoglycans in a small confined space without degradation of 
the latter. It has been hypothesised that the proteoglycan core protein is protected 
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from proteolytic degradation by clustering of GAGs (Rönnberg, Melo & Pejler, 
2012). 
FcεRI. FcεRI is a high-affinity receptor for the Fc portion of IgE4. Mast cell 
FcεRI is a tetrameric protein complex composed of an α-subunit (IgE binding), 
β-subunit (signalling) and γ-homodimer (signalling). The complete tetramer 
structure is referred to as αβγ2. IgE binding to FcεRI results in the release of 
granule content – so called degranulation (see Activation below) (Kraft & Kinet, 
2007). 
1.2.3 The Mast Cell in Mice & Humans 
Mast cell research makes great use of mouse and human models. Hence, it is of 
interest to consider the species-dependent differences in mast cells in mice and 
humans. Within either species, mast cells are present as distinct subpopulations. 
At the species level, mast cells differ by the contents of protease, proteoglycan 
and biogenic amines. At the subpopulation level, they are distinguished by the 
contents of protease (human) or protease and proteoglycan, as well as the tissue 
localisation (mouse). Human mast cells are categorised as MCT (containing 
tryptase), MCC (containing chymase) or MCTC (containing tryptase and 
chymase). Mouse mast cells are classified as either MMC (mucosal type) or 
CTMC (connective tissue type) (Buckley et al., 2006; Moon et al., 2010) (Table 
1). 
Table 1. Mast cell subpopulations in mice and humans. 
 Mouse  Human   
 MMC CTMC MCT MCC MCTC 
Tryptase - mMCP-6 
mMCP-7 
+ - + 
Chymase mMCP-1 
mMCP-2 
mMCP-4 
mMCP-5 
- + + 
Carboxypeptidase A3 - + - + + 
Proteoglycan Chondroitin 
sulphate 
Heparin Heparin 
Chondroitin 
sulphate 
Heparin 
Chondroitin 
sulphate 
Heparin 
Chondroitin 
sulphate 
Biogenic Amines Histaminea  
Serotonin 
Histaminea 
Serotonin 
Histamine 
Serotonin 
Histamine 
Serotonin 
Histamine 
Serotonin 
aLess in MMC than in CTMC (<1 pg/cell compared with >15 pg/cell) 
                                                        
4. The low-affinity receptor FcεRII is expressed on B cells (Stone, Prussin & Metcalfe, 2010) 
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1.2.4 Mast Cell Mediators 
Mast cells produce two distinct categories of mediators: preformed mediators 
and de novo synthesised mediators (Gri et al., 2012). Preformed mediators are 
stored inside the cytoplasmic secretory granules and are released within seconds 
of activation. These mediators include biogenic amines, proteoglycans, 
proteases and lysosomal enzymes (Wernersson & Pejler, 2014). The de novo 
synthesised mediators are generated first upon mast cell activation and are 
released within minutes to hours of activation, depending on the mediator type. 
These mediators include eicosanoids, cytokines, chemokines, growth factors and 
antimicrobial species. Eicosanoids generated by mast cells include 
prostaglandins (PGD2) and leukotrienes (LTB4, LTC4) (Boyce, 2005). Mast cells 
can synthesise a plethora of cytokines, chemokines and growth factors, with 
effects that range from pro-inflammatory (e.g., IL-1β, TNF-α) to anti-
inflammatory (e.g., IL-10) to immunomodulatory (e.g., TGF-β) (Mukai et al., 
2018). Compounds with direct antimicrobial effects have also been found to be 
produced by mast cells, e.g., antimicrobial peptides (Di Nardo, Vitiello & Gallo, 
2003; Di Nardo et al., 2008). Taken together, mast cell mediators have the 
potential to exert a wide range of effects on the immune system and on microbes 
(Table 2). 
Table 2. Major mast cell mediator classes and examples of mediators belonging to those classes. 
Mediator Class Effects (e.g.) Reference 
Preformed   
Biogenic Amines Vasodilation, Leucocyte regulation, 
Vasoconstriction 
Barnes, 2001 
Restricted Proteases Recruitment of neutrophils, Tissue 
homeostasis, Toxin degradation 
Pejler et al., 2010 
Non-restricted Proteases Tissue remodelling Wernersson & Pejler, 2014 
Proteoglycans Affect protease activity Rönnberg, Melo & Pejler, 
2012 
Lysosomal enzymes Tissue remodelling Gri et al., 2012 
De novo   
Cytokines Pro-inflammatory, Anti-
inflammatory 
Mukai et al., 2018 
Chemokines Leucocyte chemotaxis Mukai et al., 2018 
Growth Factors Promotion of cell growth (various 
cell types) 
Mukai et al., 2018 
Eicosanoids Leucocyte recruitment, Vascular 
permeability, Smooth muscle 
constriction 
Boyce, 2005 
Antimicrobial Compounds Direct antimicrobial effects Gri et al., 2012 
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1.2.5 Mast Cell Receptors 
Mast cells express a great variety of receptors belonging to several different 
receptor families, including: (1) Fc receptors, (2) TLRs, (3) mannosylated 
receptors, (4) complement receptors, (5) cytokine receptors and (6) chemokine 
receptors (Gri et al., 2012) (Table 3). 
Table 3. Major receptor families expressed by mast cells, examples of receptors belonging to those 
families and examples of ligands. 
Family/Type Receptor 
(e.g.) 
Ligands (e.g.) Mouse Human Reference 
Fc FcεRI IgE + + Kraft & Kinet, 2007 
 FcγRa IgG + + Malbec & Daëron, 2007 
TLRsb TLR1 Lipopeptides + + Applequist, Wallin & 
Ljunggren, 2002 
Kulka et al., 2004 
 TLR2 PGN, LTA + + Applequist, Wallin & 
Ljunggren, 2002 
Kulka & Metcafle, 2006 
 TLR3 dsRNA + + Matsushima et al., 2004 
Kulka et al., 2004 
 TLR4 LPS + + Applequist, Wallin & 
Ljunggren, 2002 
Kubo et al., 2007 
 TLR5 Flagellin  + Kulka et al., 2004 
 TLR6 LTA + + Applequist, Wallin & 
Ljunggren, 2002 
Kulka et al., 2004 
 TLR7 ssRNA + + Matsushima et al., 2004 
Kulka et al., 2004 
 TLR8 ssRNA + + Supajatura et al., 2001 
Kulka et al., 2004 
 TLR9 DNA + + Matsushima et al., 2004 
Kulka et al., 2004 
Mannosylated CD48 FimH +  Malaviya et al., 1999 
Complement C3aR C3a + + Schäfer et al., 2013 
el-Lati, Dahinden & Church, 
1994 
 C5aR C5a + + Schäfer et al., 2013 
Füreder et al., 1995 
Cytokine c-kit SCF + + Chen et al., 1994 
Hauswirth et al., 2006 
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Family/Type Receptor 
(e.g.) 
Ligands (e.g.) Mouse Human Reference 
 IL-3R IL-3 + + Wright et al., 2006 
Dahl et al., 2004 
Chemokine CCR1 CCL5 + + Amin et al., 2005 
Oliveira & Lukacs, 2001 
 CCR2 CCL2 +  Oliveira & Lukacs, 2001 
 CCR4 CCL17  + Amin et al., 2005 
aFcγRI in human, FcγRIII in mouse, FcγRII in both human and mouse 
bLigands: Akira & Takeda, 2004 
1.2.6 Mast Cell Activation 
Mast cells can be activated dependently or independently of IgE. IgE-
independent activation can be mediated by, for example, IgG, TLR ligands and 
complement components. The response of the mast cell varies with the stimuli 
(Frossi, De Carli & Pucillo, 2004). 
IgE-dependent. IgE binds with high affinity to FcεRI receptors on the mast 
cell surface. Upon exposure to IgE and antigen, FcεRI receptors will cross-link 
and initiate an intracellular signalling cascade (Kraft & Kinet, 2007). A key 
feature of this cascade is the mobilisation of intracellular Ca2+ (Wernersson & 
Pejler, 2014), which ends in the release of mast cell granule content, 
degranulation, as well as de novo synthesis of mediators (Kraft & Kinet, 2007). 
Degranulation occurs within seconds, release of eicosanoids within minutes and 
de novo protein mediators within hours of activation (Abraham & St John, 2010). 
After activation, mast cells replenish their granules. Granule replenishment 
occurs over a long period of time, up to 72 hours. Upon full regranulation, mast 
cells can participate in a new activation cycle (Blank, 2011). 
IgE-independent. IgG-mediated activation of mast cells occurs through the 
FcγR receptor upon antibody binding to antigen. IgG-mediated activation results 
in mast cell degranulation (Malbec & Daëron, 2007). TLR-mediated activation 
of mast cells typically results in the release of mediators in the absence of 
degranulation, i.e., the synthesis and release of de novo mediators such as 
eicosanoids and cytokines (Sandig & Bulfone-Paus, 2012). However, some TLR 
ligands can induce degranulation, such as peptidoglycan (PGN) (Supajatura et 
al., 2002). Activation of mast cells by complement compounds has been 
observed to enhance IgE-mediated degranulation (Schäfer et al., 2013). 
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1.2.7 The Mast Cell in the Immune System 
The mast cell constitutes something of a paradox. It is evolutionary preserved in 
all vertebrates, expresses a wide range of receptors and can synthesise a broad 
range of mediators (Crivellato & Ribatti, 2010; Gri et al., 2012). These 
observations would lead one to suppose that the mast cell has an indispensable 
and multifunctional role in the immune system. However, the most well 
documented activity attributed to the mast cell to date is its essential role in 
mediating allergic disease, i.e., the inflammation resulting from IgE-mediated 
mast cell activation and degranulation in response to innocuous antigens 
(Rodewald & Feyerabend, 2012). Beyond this well-documented activity, mast 
cells have been reported to participate in a wide range of contexts, such as the 
degradation of animal toxins, in tumour development, angiogenesis, diabetes 
and obesity (Norrby, 2002; Metz et al., 2006; Schneider et al., 2007; Ribatti & 
Crivellato, 2012; Shi & Shi, 2012). These seemingly contradictory reports have 
posited the mast cell as both a negative and positive modulator of immunity 
(Galli, Grimbaldeston & Tsai, 2008). 
The notion that mast cells are involved in host responses towards bacterial 
exposure is based on the observation that these cells: (1) express receptors for 
detecting bacterial compounds (Table 3), (2) synthesise compounds that can 
modulate other immune cells or have direct antimicrobial effects (Table 2) and 
(3) are localised at the ideal position to detect bacterial pathogens (i.e., tissues 
directly exposed to the external environment). Taken together, these 
observations are the basis of the idea of the mast cell as a ‘sentinel cell’, a first 
line of defence against invading pathogens (Galli, Maurer & Lantz, 1999). In 
agreement with the general notion of the mast cell as a mediator of both positive 
and negative effects, it has been reported to have both a protective and a 
detrimental impact on the course of infections (Johnzon, Rönnberg & Pejler, 
2016). 
Protective. The protective functions of mast cells in bacterial infection have 
been reported to be dependent on the (1) recruitment of immune cells to the site 
of infection, (2) modulation of inflammatory cell function, (3) interactions with 
cells of the adaptive immune system and (4) direct antimicrobial effects (Table 
4). Recruitment. The first studies that suggested a role for mast cells in bacterial 
infection attributed an essential role for mast cell-derived TNF-α in the 
recruitment of neutrophils (Echtenacher, Männel & Hultner, 1996; Malaviya et 
al., 1996). Other mast cell-derived neutrophil chemoattractants are leukotrienes, 
CXCL1 and CXCL2, and tryptase (Malaviya & Abraham, 2000; Thakurdas et 
al., 2007; De Filippo et al., 2013). Modulation. Mast cells have been shown to 
enhance the antimicrobial activity of neutrophils against the bacteria Klebsiella 
via an IL-6-dependent mechanism (Sutherland et al., 2008). Mast cells have also 
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been observed to inhibit replication of the bacteria Francisella tularensis (F. 
tularensis) inside macrophages in an IL-4 and contact-dependent manner 
(Ketavarapu et al., 2008). Adaptive Immune System. Mast cells have been shown 
to impact the recruitment of CD4+ cells to draining lymph nodes during 
Escherichia coli (E. coli) infection, the recruitment of dendritic cells into 
draining lymph nodes in response to Staphylococcus aureus (S. aureus) PGN 
and into infected tissues during E. coli infection (McLachlan et al., 2003; 
Shelburne et al., 2009; Dawicki et al., 2010). Antimicrobial Effects. Several 
studies have shown that mast cells possess the ability to directly kill bacteria via 
phagocytosis, the secretion of antimicrobial peptides and the release of mast cell 
extracellular traps (Malaviya et al., 1994; Di Nardo, Vitiello & Gallo, 2003; Di 
Nardo et al., 2008; von Köckritz-Blickwede et al., 2008). 
Detrimental. The detrimental impact of mast cells in the context of bacterial 
infections have been reported in terms of (1) mast cell activation, (2) immune 
evasion and (3) suppression (Table 4). Activation. In models of severe 
polymicrobial sepsis and Salmonella typhimurium (S. typhimurium) infection, 
mast cells have been shown to have a negative impact on the host, an effect that 
is dependent on TNF-α and IL-4. IL-4 has been observed to aggravate the disease 
by inhibiting phagocytosis by macrophages (Piliponsky et al., 2010; Dahdah et 
al., 2014). Evasion. Both Mycobacterium tuberculosis (M. tuberculosis) and S. 
aureus have been shown to persist intracellularly inside mast cells (Muñoz, 
Rivas-Santiago & Enciso, 2009; Abel et al., 2011). Survival inside immune cells 
is a common mechanism exploited by pathogens to evade the immune system 
(Finlay & McFadden, 2006). Mast cells appear to be no exception to this 
phenomenon. Suppression. S. typhimurium have been shown to be able to 
suppress the neutrophil-recruiting activity of mast cells by using a tyrosine 
phosphatase (SptP) in vivo. The bacterium delivers this protein into mast cells, 
thereby inhibiting their activation (Choi et al., 2013). Similarly, commensal 
bacteria have been shown to inhibit mast cell activation, possibly as a 
mechanism of homeostasis. High densities of non-pathogenic E. coli have been 
found to inhibit the activation of mast cells both in vitro and ex vivo (Magerl et 
al., 2008). A combination of four different probiotic bacterial strains upregulate 
the expression of anti-inflammatory genes in mast cells (Oksaharju et al., 2011). 
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Table 4. Protective and detrimental effects mediated by mast cells in response to bacterial 
infections or stimuli with bacterial components. 
Effect  Example Reference 
Protective   
Recruitment Neutrophil recruitment Echtenacher, Männel & 
Hultner, 1996 
Malaviya et al., 1996 
Malaviya & Abraham, 2000 
Thakurdas et al., 2007  
De Filippo et al., 2013 
Modulation Enhance neutrophil activity Sutherland et al., 2008 
 Inhibition of intramacrophage F. 
tularensis replication 
Ketavarapu et al., 2008 
Adaptive Immune System Recruitment of CD4+ cells and 
dendritic cells into draining 
lymph nodes during E. coli 
infection 
McLachlan et al., 2003  
Shelburne et al., 2009 
 
 Recruitment of dendritic cells 
into draining lymph nodes in 
response to S. aureus PGN 
Dawicki et al., 2010 
Antimicrobial Effects Antimicrobial peptides Di Nardo, Vitiello & Gallo, 
2003 
Di Nardo et al., 2008 
 Phagocytosis Malaviya et al., 1994 
 Extracellular traps von Köckritz-Blickwede et al., 
2008 
Negative   
Activation Increased mortality rate in 
enterobacterial infection models 
Piliponsky et al., 2010 
Dahdah et al., 2014 
Evasion Intracellular survival of S. aureus Abel et al., 2011 
 Intracellular survival of M. 
tuberculosis 
Muñoz, Rivas-Santiago & 
Enciso, 2009 
Suppression Suppression by S. typhimurium 
via SptP 
Choi et al., 2013 
 Upregulation of anti-
inflammatory genes by probiotic 
bacteria 
Oksaharju et al., 2011 
 
1.2.8 The Mast Cell & Vascular Endothelial Growth Factor 
Human and mouse mast cells have been shown to store vascular endothelial 
growth factor (VEGF; also called VEGF-A) in their granules and release it in 
response to a variety of stimuli, including IgE receptor cross-linking (Boesiger 
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et al., 1998; Grützkau et al., 1998). The observation that mast cells express 
VEGF has led to the notion that mast cells are involved in angiogenesis, for 
example, in the context of tumour growth (Norrby, 2002; Ribatti & Crivellato, 
2012). VEGF is a member of the VEGF gene family of growth factors (Byrne, 
Bouchier-Hayes & Harmey, 2005).5 VEGF is a glycoprotein with an essential 
role in angiogenesis (the formation of blood vessels from pre-existing vessels) 
and vasculogenesis (de novo formation of blood vessels) (Robinson & Stringer, 
2001). In humans, the VEGF gene produces at least eight different isoforms 
(VEGF110, VEGF121, VEGF145, VEGF148, VEGF165, VEGF183, VEGF189 and 
VEGF206) (Hoeben et al., 2004). In mice, three splice variants are known 
(VEGF120, VEGF164 and VEGF188) (Ng et al., 2001). The isoforms vary in terms 
of their potency in inducing angiogenesis, ability to diffuse, extent of expression 
and tissue specificity (Berse et al., 1992; Ng et al., 2001; Hoeben et al., 2004). 
Interestingly, in the context of mast cells, VEGF diffusibility is determined by 
its ability to bind heparin/heparan sulphate. Isoforms lacking heparin binding 
domains are more diffusible than those expressed with these domains (Ng et al., 
2001; Hoeben et al., 2004).  
1.2.9 Mast Cell Models 
Mast cells are traditionally studied using in vitro models (human, mouse) and in 
vivo models (mouse). Both primary cells and cell lines are routinely employed 
in mast cell in vitro studies. Primary mast cells can be derived from the bone 
marrow (bone marrow-derived mast cells; BMMCs) or peritoneum (peritoneal 
cell-derived mast cells; PCMCs) of mice, or from human tissue (Malbec et al., 
2007; Arock et al., 2008; Passante, 2014). An important tool in in vivo studies 
of mast cells are mast cell-deficient mice. There are two classes of these models: 
(1) kit-dependent deficient mice and (2) kit-independent deficient mice. c-Kit is 
the receptor for stem cell factor (SCF), the principal growth factor for mast cells 
(Moon et al., 2010). 
c-Kit-dependent. Mutants with deficient Kit proteins have different 
phenotypes: KitW, KitWv, KitW-sh and KitW/Wv. In KitWv mice, c-Kit has impaired 
kinase activity (Nocka et al., 1990). KitW-sh mice have impaired expression of 
Kit due to a genomic rearrangement (Berrozpe et al., 1999). KitW/Wv mice are 
produced by crossing KitW and KitWv mice and have been extensively used in 
mast cell research. A key aspect of these phenotypes is that the c-Kit receptor is 
also expressed by many other cells during development; hence, mutations 
affecting c-Kit have consequences for tissues and cells beyond the lack of mast 
cells. These effects may influence the outcome of experiments and lead to 
                                                        
5. Also includes the members VEGF-B, VEGF-C and VEGF-D 
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erroneous conclusions regarding the roles of mast cells (Rodewald & 
Feyerabend, 2012). 
c-Kit-independent. Mice in which the mast cell deficiency results from an 
alteration independent of c-Kit were developed in response to the concerns 
raised regarding the validity of the older c-Kit-dependent models. These 
deficiencies are either constitutive or inducible. Constitutively mast cell-
deficient mice are established from birth. In inducible models, the mast cell 
deficiency only develops in response to infusion of a toxin into a genetically 
modified animal (Rodewald & Feyerabend, 2012). The mast cell deficiency in 
these models depends either on the Cre recombinase system or on the addition 
of constitutively expressed diphtheria toxin receptors. By ensuring that the 
expression of the added genetic elements is under the control of mast cell-
specific genes (proteases, enhancers), the alteration is restricted to mast cells 
(i.e., Cre recombinase is only active in mast cells) (Dudeck et al., 2011; Otsuka 
et al., 2011; Feyerabend et al., 2011; Lilla et al., 2011; Sawaguchi et al., 2012). 
For example, in Mcpt5-Cre R-DTA mice, the Cre-recombinase is controlled by 
the promoter for Mcpt-5 (gene encoding mMCP5). Cre-recombinase catalyses 
the recombination of specific DNA fragments (loxP) located at either ends of a 
larger DNA sequence, in this case a sequence containing the stop codon for the 
genes encoding diphtheria toxin (DT). Expression of Mcpt-5 leads to expression 
of the Cre-recombinase and removal of the DT stop codon, enabling the 
expression of DT. DT expression leads to mast cell death (Brault et al., 2007; 
Dudeck et al., 2011). Regardless of how the c-Kit-independent mast cell 
deficiency is induced, these mice have fewer abnormalities compared with the 
older c-Kit-dependent models. Hence, they are believed to be a more powerful 
research tools (Feyerabend & Rodewald, 2012). 
 
1.3 Mastitis 
1.3.1 Modern Domestic Cattle 
Cattle are large domesticated ruminant ungulates (Adelsköld et al., 1923). 
Modern domestic cattle are split into two species, taurine cattle (Bos taurus) and 
zebus (Bos indicus) descended from aurochs (Bos primigenius). A third species, 
sanga cattle, is an African species of mixed taurine:zebu ancestry (Ajmone-
Marsan et al., 2010). In 2016, the global population of cattle was estimated to be 
in excess of one billion individuals (FAOSTAT, 2016). In Sweden, the cattle 
population is estimated to include approximately 1400000 individuals (Grönvall, 
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2018). The Swedish Red-and-White (SRB) and Swedish Friesian (SLB) are the 
most common breeds amongst dairy cows (Växa, 2018). Since their 
domestication, cattle have provided human societies with draught power, milk, 
meat and hides (Ajmone-Marsan et al., 2010). The influence of cattle on human 
culture is attested by their frequent depiction in art and appearance in religion. 
The depictions of bull sports in Minoan art, of milking in Ancient Egyptian art 
and the cow Audumla, of Norse Mythology, who gave her milk to Ymir, the first 
being, are but a handful of examples of the influence that this animal species has 
had on human civilisation (Loughlin, 2000; Encyclopaedia Britannica). In this 
thesis, the term bovine will be used to refer to cattle. 
1.3.2 The Composition of Milk 
Milk is a complex biological emulsion of water and fat along with two other 
major milk constituent classes: proteins and sugars (lactose). It also contains 
many other substances, e.g., minerals and vitamins. Milk is the main source of 
nutrition for the mammalian neonate. Hence, it must contain all the nutrients 
required for growth. Milk fats released into the liquid as membrane-enclosed 
globules, and lactose, the disaccharide of glucose and galactose, act as sources 
of energy. Milk proteins, caseins and whey proteins, provide the amino acids 
required for the growth of tissues. The exact proportions of the different 
components vary considerably between different mammalian species. For 
example, the milk of marine mammals and polar bears contain more fat than the 
milk from other mammals. Human and bovine milk, as relevant examples, vary 
in the content of lactose, total protein, and the ratios of casein and whey, fats and 
minerals (Björnhag, 2004; Fox et al., 2015) (Table 5). 
Table 5. Comparison of the composition of human and bovine milk in terms of lactose, protein, fat 
and minerals. 
Component Human Bovine 
Lactose (g/100 g) 6,3 – 7,0 4,4 – 5,6 
Protein (g/100 g) 0,9 – 1,9 3,0 – 4,0 
Approximate casein:whey ratio 40:60 80:20 
Fat (g/100 g) 2,1 – 4,0 3,3 – 6,4 
--Saturated (%) 36 – 45 55 – 73 
--Monounsaturated (%) 44 – 45 22 – 30 
--Polyunsaturated (%) 8 – 19 2,4 – 6,3 
Minerals (g/100 g) 0,2 – 0,3 0,7 – 0,8 
References: Fox et al., 2015; Gantner et al., 2015 
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1.3.3 A Brief Overview of the Mammary Secretory Tissue 
The bovine udder is quartered. Each quarter is functionally distinct with no direct 
connections. The right and left side of the udder are separated by thick 
connective tissue bands. The front and rear quarter on one side are only separated 
by a thin connective tissue septum. The whole udder is supported by a number 
of connective tissue bands, including the bands separating the two udder halves. 
The secretory tissue of one quarter is divided into the following components: (1) 
alveoli (singular: alveolus), (2) milk ducts and (3) connective tissue. The 
function of the gland connective tissue is to protect the more delicate alveoli 
(Nickerson & Akers, 2011).  
The globular alveoli are the functional units of the secretory tissue. An 
alveolus consists of a single layer of specialised epithelial cells surrounding a 
hollow cavity. These epithelial cells, also called mammary epithelial cells 
(MECs) or simply mammocytes, absorb compounds from the blood and convert 
them into milk components. The milk is secreted into the hollow cavity. The 
mammary epithelial layer is surrounded by myoepithelial cells, a type of smooth 
muscle cell. Capillaries connect each alveolus to the general circulation. Milk 
accumulates inside an alveolus and, upon contraction of the myoepithelial cells, 
is forced out through a single duct – an opening providing egress from the 
alveolus. Alveoli are clustered together, and the duct of each alveolus connects 
them into a larger duct system. This system drains into the gland cistern. The 
gland cistern is in turn connected to the teat cistern. Milk is drained from the teat 
cistern through the teat canal. A sphincter6 closes the teat canal and prevents 
leakage. 
The udder is supplied with a very plentiful blood flow by arteries entering 
both halves of the udder near the rear quarters. Blood is drained from the 
mammary gland primarily through veins exiting from the front and rear of the 
udder. The udder possesses two large lymph nodes, one in each udder half. Milk 
synthesis is controlled by hormones, the release of which is controlled by the 
nervous system. The nervous system is otherwise not directly involved in the 
control of milk synthesis (Björnhag, 2004; Nickerson & Akers, 2011; Fox et al., 
2015). 
1.3.4 The Innate Immune System of the Mammary Gland 
The innate immune system of the mammary gland is divided into: (1) resident 
defences, (2) inducible defences and (3) cellular defences7. The resident 
                                                        
6. Circular smooth muscle 
7. Cellular defences are considered to be a part of the resident defences. I have chosen to detail 
them separately for the sake of clarity 
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defences are constitutively present in the udder, whereas the inducible defences 
must be mobilised in response to an infection. Cellular defences are represented 
both by the resident population of leucocytes and by leucocytes that are recruited 
into the gland during inflammation (Rainard & Riollet, 2006). 
Resident Defences. Resident defences are partly composed of anatomical 
barriers and partly of humoral defences. Between milkings, the teat canal is 
blocked by a keratin plug generated from the epithelial cells of the teat cistern. 
It constitutes a simple anatomical barrier to pathogen entry into the mammary 
tissue. The humoral defences are composed of a series of proteins present in the 
milk, including components of the complement system (C3b, C5a), lactoferrin 
(iron-chelator), transferrin (iron-chelator), lysozyme (an enzyme targeting PGN) 
and opsonic antibodies produced in the absence of antigenic stimulation (IgM). 
Inducible Defences. Numerous genes are activated in mammary cells in 
response to infection, including nitric oxide synthase (iNOS; catalyses the 
formation of nitric oxide), host defence peptides (short proteins with 
antibacterial activity) and lactoferrin (concentration in milk increases 
dramatically upon inflammation) (Rainard & Riollet, 2006).  
Cellular Defence. Three cell types are important for the innate immune 
system in the mammary gland: (1) MECs, (2) neutrophils and (3) macrophages 
(Rainard & Riollet, 2006; Ezzat Alnakip et al., 2014). Mast cells have also been 
demonstrated to be present in the udder (Nielsen, 1975).  
Cellular Defences of the Innate Immune System of the Mammary Gland 
Leucocytes involved in the mammary immune system are primarily 
macrophages and neutrophils (Rainard & Riollet, 2006; Ezzat Alnakip et al., 
2014). Both MECs and macrophages have been identified as possible activators 
of inflammation in the mammary tissue in response to bacterial infection (Elazar 
et al., 2010; Brenaut et al., 2014). 
Mammary Epithelial Cells. Aside from their milk synthesis function, MECs 
synthesise a wide range of inflammatory mediators following exposure to 
bacterial stimuli. In several in vitro experiments, MECs have been shown to 
express several cytokines in response to stimuli with purified bacterial 
components, conditioned media or heat-inactivated bacterial cells – e.g., CCL2, 
TNF-α, IL-1β, IL-6 and IL-8 (Strandberg et al., 2005; Fu et al., 2013; Gilbert et 
al., 2013). In an ovine in vivo infection model of S. aureus mastitis, MECs 
orchestrated the early stages of the inflammatory response based on a 
mechanism that was dependent on IL-8 (Brenaut et al., 2014). Hence it is 
possible that bovine MECs share a similar ‘activator of inflammation role’ 
during bacterial infection. 
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Neutrophils. The function of the resident mammary neutrophil population is 
not clear. However, the recruited neutrophil population becomes the 
predominant leucocyte in the mammary gland during inflammation (Rainard & 
Riollet, 2006). In a healthy gland, neutrophils make up 3 – 26% of the total 
leucocytes in milk. In an inflamed gland, they reach up to 90% of the total 
leucocytes (Ezzat Alnakip et al., 2014). Once inside the mammary gland, these 
neutrophils have the same function as they do elsewhere in the host – to 
neutralise invading pathogens. A distinguishing feature of the mammary 
neutrophils is their reduced antimicrobial activity compared with neutrophils in 
other tissues. Upon entry into the mammary gland, neutrophils engulf milk fat 
globules and proteins, leading to a reduction in the number of granules available 
for killing ingested microbes (Paape et al., 2003). However, they remain able to 
deal with invading microbes, possibly due to their sheer numbers (Blowey & 
Edmondson, 2010). 
Macrophages. As in other tissues, the resident mammary macrophage 
population represents the potential initiators of the inflammatory response 
(Rainard & Riollet, 2006). In a mouse model of mastitis, the mammary 
macrophage population was demonstrated to be essential in the recruitment of 
neutrophils into the mammary gland in response to lipopolysaccharide (LPS) 
infusion. The mechanism was dependent on TNF-α and TLR4 signalling (Elazar 
et al., 2010). Bovine macrophages have been shown to be able to phagocytose 
mastitis pathogens in vitro and release chemoattractants in response to S. aureus 
(Politis et al., 1991; Grant & Finch, 1997). As in other tissues, monocytes are 
recruited into the mammary gland during inflammation. They differentiate into 
macrophages and are essential in the resolution of inflammation by clearing 
away neutrophils, as described elsewhere (see Inflammation) (Paape et al., 
2003). Macrophages are the predominant leucocyte in healthy glands, 
constituting up to 79% of the total leucocyte content in milk. In an inflamed 
gland, this proportion falls to 9 – 32% (Ezzat Alnakip et al., 2014).  
The Bovine Mast Cell 
Mast cells are present in the udder, where they are the primary source of 
histamine (Nielsen, 1975; Maslinski et al., 1993; Beaudry et al., 2016). The 
bovine mast cell is a little studied area in comparison with those of mice and 
humans. A few studies have attempted to elucidate bovine mast cell 
heterogeneity and tissue distribution. Like human mast cells, bovine mast cells 
are divided into three subtypes based on their protease content: MT, MTC and 
MC. Tryptase-positive mast cells are present in all sections of studied tissues, 
whereas chymase status varies (Küther et al., 1998; Jolly et al., 1999). Chymase-
positive mast cells are more numerous in connective tissues than in mucosal 
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tissues (Jolly et al., 2000). It remains to be determined whether bovine mast cells 
express more than one type of tryptase or chymase, but methodological 
discrepancies suggest that the proteases are heterogenous as in mice and humans 
(Jolly et al., 1999; Jolly et al., 2000). 
1.3.5 Mastitis  
Mastitis is an inflammation of the mammary tissue (Adelsköld et al., 1923; 
Erskine, 2016). It typically arises as a response to an intramammary infection 
(IMI). Though commonly of bacterial origin, IMIs can also be caused by algae 
and fungi. Viruses are also possible mastitis pathogens (Dion, 1982; Watts, 
1988; Bradley, 2002; Wellenberg, van der Poel & Van Oirschot, 2002). Mastitis 
is marked by the five cardinal signs of inflammation: reddening of the tissue, 
swelling of the tissue, pain in the inflamed tissue, an increased temperature in 
the tissue and impaired function. The latter is manifested as a reduced milk yield 
(Erskine, 2016).  
Activation of Inflammation in the Mammary Gland 
As noted previously, both MECs and the resident population of mammary 
macrophages are potential activators of the inflammatory response in the bovine 
mammary gland (Elazar et al., 2010; Brenaut et al., 2014). Cows, like other 
mammals, express the repertoire of TLRs 1 – 10 (Menzies & Ingham, 2006). 
Minimally, TLR2 and TLR4 agonists are detected by bovine MECs, e.g., LPS 
and lipoteichoic acid (LTA) (Gilbert et al., 2013). 
Effect of Mastitis on Milk & Economic Impact 
Mastitis has numerous effects on milk apart from the reduced yield. The 
proportions of proteins, fats, ion concentrations, pH and concentrations of 
enzymes are altered in milk from an inflamed gland (Kitchen, 1981). These 
changes will, in turn, affect the taste of the milk and the possibility of further 
processing, e.g., the manufacturing yield is lower from mastitic milk due to the 
reduction of casein levels (Blowey & Edmondson, 2010). The recruitment of 
leucocytes in the mammary gland is also measurable in milk as an increase in 
milk somatic cell counts (SCCs). SCCs are primarily composed of neutrophils 
and macrophages that are recruited into the udder (Ezzat Alnakip et al., 2014). 
SCCs are given in cells/ml and are used to measure the quality of the milk. High 
levels are considered to indicate poor milk quality. Additionally, increased levels 
are directly associated with reduced milk yield (Schukken et al., 2003; 
Hagnestam-Nielsen et al., 2009). SCCs are measured on the herd level or on 
40 
 
individual level. Herd level SCCs are performed using the bulk tank milk. Apart 
from determining the total quality of the milk from one dairy herd, bulk tank 
SCCs (BTSCCs) are also used to follow changes in SCCs over time. High 
BTSCCs typically indicate the presence of subclinical mastitis cases (Blowey & 
Edmondson, 2010). National standards for BTSCCs vary considerably. Within 
the European Union as well as Australia, New Zealand and Canada the levels 
are <400,000 cells/ml. In the United States, the level is 750,000 cells/ml (USDA, 
2016). Individual cow SCCs (ICSCCs) can be used to identify specific 
individuals with high SCCs (Blowey & Edmondson, 2010). On the individual 
level, uninfected quarters have been found to have a mean SCCs of 70,000 
cells/ml (Schukken et al., 2003). 
Taken together, mastitis incurs economic costs in terms of a reduced milk 
yield and quality, veterinary costs (diagnostics and treatment) and culling of 
incurable cases. Mastitis is considered to be one of the most economically 
destructive diseases in the dairy industry worldwide (Halasa et al., 2007; 
Hogeveen, Huijps & Lam, 2011) and it is reported in dairy herds on a global 
scale (Persson Waller et al., 2009; Östensson et al., 2013; Abebe et al., 2016; 
Levison et al., 2016; Busanello et al., 2017; Gao et al., 2017). 
Clinical Forms of Mastitis 
Mastitis manifests itself in two forms: (1) clinical mastitis and (2) subclinical 
mastitis. Clinical mastitis is characterised by visually distinguishable symptoms 
in both the udder and the milk. Visible alterations in the milk include a change 
in colour (white to yellow) and the appearance of clots. Clinical mastitis cases 
restricted to local symptoms are termed mild. Cases with systemic symptoms, 
such as fever or anorexia, are termed severe. Cases with rapidly developing 
symptoms are termed acute. In subclinical mastitis visible changes in the udder 
and the milk are at most transient. However, a reduction in milk yield and 
increased SCCs are still present. Subclinical mastitis cases that persist for at least 
two months are termed chronic. Due to the lack of easily recognisable symptoms, 
subclinical mastitis cases are difficult to detect (Erskine, 2016). 
Mastitis Bacterial Pathogens & Differential Immune Response 
Mastitis pathogens are traditionally divided into two general types: (1) 
contagious pathogens and (2) environmental pathogens. Contagious mastitis 
pathogens are present as reservoirs inside the mammary gland and can spread 
from one animal to another. Environmental pathogens are opportunistic and 
originate from outside the animal. In general, contagious mastitis pathogens 
cause subclinical mastitis whereas environmental pathogens cause clinical 
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mastitis (Blowey & Edmondson, 2010). However, although microbial species 
are typically categorised as one or the other of these two classes, the distinctions 
are less apparent on the strain level (Bradley, 2002).  
Common mastitis bacterial pathogens are streptococci, staphylococci and 
coliforms (Blowey & Edmondson, 2010). In Sweden, two common bacterial 
mastitis pathogens are S. aureus and E. coli (Ericsson Unnerstad et al., 2009). 
These two species also represent the two types of mastitis pathogens: S. aureus 
is generally considered a contagious pathogen and E. coli an environmental 
pathogen. They also reflect the imperfect distinction between the two classes. 
Some E. coli strains can cause persistent infection, whereas some S. aureus 
strains cause acute infections. Virulence factors enabling iron acquisition, 
mobility and adherence are often found in E. coli strains that are able to cause 
persistent rather than transient infections with which the species is normally 
associated with (Dogan et al., 2006; Lippolis et al., 2014; Fairbrother et al., 
2015). In S. aureus, genes encoding superantigens and antibiotic resistance 
mechanisms are typically found in persistent strains (Haveri et al., 2007). E. coli 
and S. aureus are also good examples of the contrasting immune responses that 
different species can provoke (Schukken et al., 2011). E. coli typically elicit a 
rapid cytokine response, including IL-1β, IL-8 and TNF-α. S. aureus elicits a 
cytokine profile including IL-1β and interferon (IFN)-γ. This response is slower 
and yields lower cytokine concentrations (Bannerman, 2009) (Table 6). 
Treatments & Diagnostics 
The diagnosis of mastitis is based on both clinical examination of the affected 
animals and an examination of the milk (Duarte, Freitas & Bexiga, 2015; 
Erskine, 2016). The milk can be examined for visible changes as well as with 
more refined methodology. An increase in SCCs is the gold standard for 
detecting cases of subclinical mastitis (Duarte, Freitas & Bexiga, 2015). 
Monitoring SCCs over time is one method used to detect suspected mastitis 
cases. However, many other factors influence SCCs apart from mastitis, 
including age, stage of lactation, stress and season. Hence, SCCs cannot be 
solely relied on and other factors, such as the history of a dairy herd, must be 
taken into consideration to determine the likelihood of mastitis (Blowey & 
Edmondson, 2010). Identification of a mastitis pathogen is based on genotypic 
(PCR) and phenotypic (milk culture) methods (Duarte, Freitas & Bexiga, 2015). 
Identification of the causative organism is a prerequisite to determine treatment 
options or other course of action (Blowey & Edmondson, 2010). 
Mastitis is typically treated with antibiotics and symptomatic treatment, e.g., 
nonsteroidal anti-inflammatory drugs (NSAIDs) (Erskine, 2016). Not 
surprisingly, antibiotic resistant strains of bacterial mastitis pathogens have been 
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isolated worldwide (Persson, Nyman & Grönlund-Andersson, 2011; Gao et al., 
2012; Saini et al., 2012). In Sweden, the use of antibiotics is limited to specific 
cases of acute clinical mastitis (Persson Waller, 2018). Other courses of action 
include milking infected cows last (to reduce the spread of infection) and culling 
(Blowey & Edmondson, 2010). 
Table 6. Comparison of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) as mastitis 
pathogens in terms of pathogen type, mastitis type, immunogenic component(s), cytokine profile 
(protein level unless otherwise stated), rectal temperature and milk somatic cell counts (SCCs). 
Cytokine level comparisons are relative. (-): no response. (+): response. (++):  stronger response. 
 E. coli S. aureus Reference 
Pathogen Typea Environmental Contagious Blowey & Edmondson, 
2010 
Mastitis Typea Clinical Subclinical Blowey & Edmondson, 
2010 
Immunogenic 
Component(s) 
LPS LTA 
Lipoproteins 
Mehrzad et al., 2008; 
Gilbert et al., 2013 
Immune Responseb 16 hours 24 – 32 hours Bannerman et al., 2004 
Cytokine Profile    
    IL-6c + ++ Lee et al., 2006 
    IL-8 + - Bannerman et al., 2004 
    TNF-α + - Bannerman et al., 2004 
    IL-1β ++ + Bannerman et al., 2004 
    IFNγ ++ + Bannerman et al., 2004 
Rectal Temperature (°C) 40,5 39 – 39,5 Bannerman et al., 2004 
SCC (106 cells/ml) >40 ~30 Bannerman et al., 2004 
aSpecies level 
bTime point where changes in cytokine expression and/or secretion, rectal temperature and SCCs levels 
first become significant 
cGene expression 
Mastitis & Metabolomics 
Metabolomics, also called metabonomics, is the study of changes in metabolites 
on a system-wide scale under certain conditions (e.g., cells in a culture) 
(Rochfort, 2005). Metabolites are molecules generated by an organism’s 
metabolism, the life-sustaining chemical processes of a living organism (Lazar 
& Birnbaum, 2012). Metabolomic studies are undertaken using techniques such 
as nuclear magnetic resonance spectroscopy (NMR) and mass spectroscopy 
(MS) (Rochfort, 2005). In the context of bovines and mastitis, the metabolic 
profiles of milk have been studied both in naturally occurring cases of disease 
and in experimentally induced disease. Such studies have found that mastitis 
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induces distinct metabolite profiles. For example, animals classified as healthy, 
clinical and subclinical have distinct milk profiles, milk classified as low or high 
SCC vary significantly with regard to a number of metabolites, and metabolite 
profiles vary over time in animals where mastitis was experimentally induced by 
infusion of bacteria (Sundekilde et al., 2013; Moyes et al., 2014; Thomas et al., 
2016; Xi et al., 2017). 
In Vivo Mastitis Models 
Both mouse and bovine in vivo models are used to study mastitis. Mouse 
models include both mammary and non-mammary models (Bogni et al.; 1998; 
Leitner, Lubashevsky & Trainin, 2003; Elazar et al., 2010). Bovine in vivo 
models include intramammary infusion or injection of purified bacterial 
components (e.g., LPS or LTA) and whole or inactivated bacteria (Yagi et al., 
2002; Leitner et al., 2003; Rainard et al., 2008; Pellegrino et al., 2010). 
Although these bovine models have some practical disadvantages in 
comparison with the mouse models, they offer the possibility of studying 
mastitis in the relevant species and tissue.  
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2.1 Aims of the Present Studies 
The objective of these studies was to investigate the inflammatory mechanisms 
in bacterial infections, with a special focus on mast cells and bovine mastitis. 
 
➢ Paper I: Investigate the induction of vascular endothelial growth factor 
(VEGF) by S. aureus in mast cells in vitro 
➢ Paper II: Investigate the activation of mast cells in vitro by S. aureus and 
the role of mast cells in S. aureus infection in vivo 
➢ Paper III: Investigate and differentiate the virulence of a set of acute mastitis 
bacterial isolates of bovine origin using an in vivo mouse infection model 
➢ Paper IV: Investigate the clinical, immunological and metabolic changes 
that occur during mastitis using an in vivo bovine model of LPS-induced 
acute mastitis 
2.2 Paper I 
VEGF is essential for promotion of the survival, proliferation and migration of 
endothelial cells. In addition to these pro-angiogenic effects, VEGF also acts as 
a chemoattractant for immune cells. Mast cells produce and secrete VEGF and 
thus are thought to be involved in angiogenesis. In a previous study (Paper II), 
a gene array revealed that VEGF was highly upregulated in mast cells stimulated 
with live Staphylococcus aureus in vitro. This phenomenon provided a hitherto 
unknown link between bacteria and the induction of VEGF in mast cells. The 
aim of this study was to further investigate this finding. As many previous 
studies had used immature mast cell models, we decided to use fully mature 
2 Present Investigations 
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mouse mast cells derived from the peritoneum of adult mice (peritoneal cell-
derived mast cells; PCMCs). 
To investigate whether mature mast cells could synthesise and release VEGF, 
PCMCs were co-cultured with S. aureus. VEGF gene expression was analysed 
by quantitative PCR. VEGF secretion was analysed by enzyme-linked 
immunosorbent assay (ELISA). We found that VEGF expression was 
upregulated after six hours of co-cultivation and a significant increase in the 
concentration of VEGF in the co-culture supernatant was seen after just two 
hours. Next, we investigated whether live whole bacteria were required to induce 
VEGF expression and secretion. Purified bacterial components LPS, LTA, 
Pam3CSK4 (PAM3), PGN or a mixture of all four), heat inactivated bacteria and 
conditioned media (bacterial growth media or PCMC media conditioned with 
bacterial growth followed by sterile filtering) failed to elicit any response at the 
gene expression level. Subsequently, we investigated whether the induction of 
VEGF expression required direct contact between the mast cell and the bacteria. 
To achieve this goal, we utilised a Transwell system. Here, the PCMCs and 
bacteria were separated by a thin membrane that allowed the diffusion of soluble 
products, but not the migration of whole bacteria. Using this system, we found 
that direct contact was not required for the induction of VEGF expression. 
Finally, we investigated which cell-signalling pathway might be involved in this 
induction. PCMCs were pre-treated with inhibitors for the adaptor molecule 
Myd88 (involved in most TLR signalling pathways), nuclear factor of activated 
T-cells (NFAT; signalling molecule involved in the induction of pro-
inflammatory genes in mast cells) and NF-κB (transcription factor involved in 
the regulation of genes related to the immune system) before co-cultivation with 
S. aureus. We observed only a partial inhibitory effect on VEGF upregulation in 
response to NF-κB inhibition. 
 
Summary of Paper I: 
➢ Induction of VEGF expression and secretion in fully mature mast cells 
requires whole live bacteria 
➢ This induction is seemingly independent of TLRs but partly dependent on the 
NF-κB pathway 
➢ VEGF induction is not dependent on direct contact between the mast cell and 
bacteria, but the soluble factor(s) involved could not be identified 
2.3 Paper II 
Many studies have focused on elucidating the role of mast cells in bacterial 
infections, primarily using immature mast cells in vitro and Kit-dependent mast 
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cell knockout mice in vivo. In this study, the role of the mast cell in bacterial 
infections was studied using mature mast cells (PCMCs) in vitro and Kit-
independent mast cell knockout mice in vivo (Mcpt5-Cre+ x R-DTA with mast 
cell competent Mcpt5-Cre- x R-DTA littermates used as controls).  
PCMCs were co-cultivated with S. aureus in vitro. Gene expression was 
comprehensively studied using an Affymetrix microarray system. This revealed 
a profound upregulation of several genes encoding pro-inflammatory cytokines, 
including IL-3, IL-13 and TNF-α. Release of these cytokines into the cell culture 
supernatant was confirmed by ELISA. 
Mice were infected with S. aureus by intraperitoneal injection. Controls were 
injected with an equivalent volume of sterile bacterial growth medium. Infection 
was allowed to proceed for four hours, one day or three days. The impact of the 
infection was monitored by weighing the mice, bacterial burden by determining 
the colony-forming unit per ml (CFU/ml) in the peritoneal lavage fluid, the 
infiltration of cells into the peritoneum by cell counting and the effect on the 
peritoneal cell population by differential cell counting. No differences were 
observed between mast cell-deficient and competent mice.  
The influence of the mast cells on the production of cytokines in the 
peritoneum was investigated using a cytokine array. Cytokines detected at high 
concentrations in this assay (IL-6, MCP-1) and cytokines from the in vitro 
experiments (IL-3, IL-13) were further investigated by ELISA. No differences 
were observed between mast cell-deficient and competent mice. 
 
Summary of Paper II: 
➢ Mast cells are activated to release cytokines in response to S. aureus in vitro 
➢ Mast cells do not influence the course of S. aureus infection in vivo nor do 
they contribute to the peritoneal cytokine profile 
2.4 Paper III 
The aim of this study was to use a non-mammary mouse infection model to 
differentiate the virulence of a selection of acute clinical mastitis bacterial 
isolates of bovine origin. Non-mammary mouse models have previously been 
used in mastitis research. In the present study, isolates of the species S. aureus 
(8325-4, 556, 392) and E. coli (MG1655, 676, 127) were used. The laboratory 
strains 8325-4 and MG1655 were used as controls. The generation time for all 
of the strains was determined and did not significantly differ in a species-based 
comparison. 
The mice were infected by intraperitoneal injection, and the infection was 
allowed to proceed for 24 hours. The infection was assessed by weighing the 
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mice, scoring the severity of infection, and weighing lymph nodes and spleens. 
Clearance of bacteria from the peritoneum was assessed by determining the 
CFU/ml in the peritoneal lavage fluid. Effects on the recruitment of immune 
cells to the peritoneum and the peritoneal cell population were determined by 
cell counting. The pro-inflammatory cytokine profile in the peritoneum was 
investigated using a cytokine array. 
E. coli strain 127 caused strikingly consistent and high clinical scores, but it 
had no effect on the lymphoid organs. Strain 127 also persisted at greater 
numbers in the peritoneum. All strains induced neutrophil recruitment. The 
concentrations of three cytokines (G-CSF, CXCL1 and CCL2) were particularly 
highly increased based on a cytokine array in mice infected with strain 127 
compared with the other strains. The concentrations of these cytokines were 
subsequently measured by ELISA in peritoneal lavage fluid (local) and plasma 
(systemic). The concentrations of these cytokines were higher in mice infected 
with 127 than any of the other strains, and correlated significantly with both the 
clinical score and bacterial burden. Hence, strain 127 caused both a local and 
systemic cytokine response. 
 
Summary of Paper III: 
➢ E. coli 127 strain consistently caused more severe infections as judged by 
clinical scoring and persisted at greater number in the peritoneum 24 hours 
after infection, but did not affect the lymphoid organs 
➢ E. coli 127 strain generated a distinct cytokine profile (G-CSF, CXCL1, 
CCL2) in both the peritoneal lavage fluid (local response) and plasma 
(systemic response) 
➢ The concentrations of these cytokines correlated with both disease severity 
and bacterial burden in the peritoneum  
2.5 Paper IV 
The objective of this study was to investigate the clinical and molecular changes 
that occur during acute bovine mastitis. A kinetic approach was applied, and 
changes were registered in terms of clinical parameters (clinical score, milk 
changes, rectal temperature), concentrations of cytokines in milk and plasma, 
and changes in the metabolome. Additionally, a role for mast cells in this model 
was investigated by analysing histamine levels in milk and plasma. Mastitis was 
induced by an intramammary infusion of LPS dissolved in physiological saline 
solution. Controls received an equivalent volume of physiological saline 
solution. Only healthy primiparous lactating cows were enrolled for the purposes 
of this study. Samples were collected in the form of milk and blood. 
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Clinical signs of mastitis in the udder (heat, pain, swelling, temperature) were 
visible two hours post-infusion and persisted up to 24 or 72 hours. Visible 
changes in the milk and a significant increase in the milk SCCs were delayed 
and appeared only after four hours. These changes also persisted for a longer 
period of time, up to 120 hours post-infusion, than did the other clinical 
parameters. Increases in the concentrations of the cytokines IL-6, TNF-α and 
CCL2 in milk were significant at two hours post-infusion. G-CSF and CXCL1 
did not significantly increase in milk. In plasma, only a transient increase in IL-
6 was detectible at four hours post-infusion. Histamine did not increase 
significantly in either milk or plasma, indicating that mast cells did not have a 
major role in the response to LPS. 
The metabolomics profiles of the milk and plasma were analysed using a 
targeted (plasma) and untargeted (milk) NMR-based analysis approach. In milk, 
major changes occurred 24 hours post-infusion, including a reduction of lactose 
levels. Hence, these changes were preceded by a significant degree of time by 
the other local changes in the udder, judged in terms of clinical parameters and 
cytokine concentrations. Changes in the plasma required less time to develop, 
where an increase in lactose together with concurrent reductions in the levels of 
ketone bodies and short-chain fatty acids were detectible four hours post-
infusion. The systemic changes in the plasma coincided with the transient IL-6 
increase in plasma. The progression of these changes can be summarised as 
follows: (1) signs of inflammation in the udder and increases in milk cytokine 
concentrations (two hours), (2) visible changes in the milk and increases in milk 
SCCs (four hours), (3) changes in the plasma metabolome (four hours) and (4) 
changes in the milk metabolome (24 hours) 
 
Summary of Paper IV: 
➢ Intramammary infusion led to visible signs of acute mastitis two hours post-
infusion, returning to normal levels within 24 to 72 hours post-infusion 
➢ Changes in the milk were delayed compared with general and systemic 
changes, but persist for longer periods of time 
➢ Concentrations of IL-6, TNF-α and CCL2 increased in milk; only a transient 
increase in levels of IL-6 was detectible in plasma 
➢ The absence of increased histamine levels in milk and plasma suggests that 
mast cells have no role in LPS-induced acute mastitis, but activation 
independent of degranulation cannot be excluded 
➢ Changes in the metabolome were registered in both the plasma and the milk, 
developing at four hours post-infusion before returning to normal within 72 
hours 
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Inflammation is an unspecific response of the immune system to trauma and 
invasion by foreign particles such as for example bacterial pathogens. 
Inflammation, due to its unspecific nature, causes collateral damage to the host 
tissue in addition to the beneficial effects of eliminating or limiting the spread 
of an infectious agent. Two common examples in which the negative impact of 
inflammation causes extensive damage to the host are mastitis (inflammation of 
the mammary tissue) and IgE-mediated hypersensitivity (activation of mast 
cells). Mast cells have also been suggested to have a role in bacterial infections, 
as a sentinel cell that is ideally positioned to respond quickly and early to the 
presence of bacteria. The inflammatory mechanisms that are operative during 
bacterial infection, in the context of mastitis and the contribution of mast cells, 
were studied using a four-pronged approach. (1) Mast cell mechanisms were 
studied in vitro using mature primary mouse mast cells and (2) in vivo using Kit-
independent mast cell-deficient mice. This strategy is in contrast to many 
previous studies in which immature mast cells and Kit-dependent mast cell-
deficient mice have been used. Mastitis was investigated: (1) in vivo using a 
mouse non-mammary infection model and (2) an LPS-induced acute bovine in 
vivo mastitis model. 
The conditions required for the synthesis and release of VEGF by fully 
mature mast cells stimulated with S. aureus were comprehensively studied in 
vitro. At this stage, the identity of the soluble factor(s), which only seemed to be 
produced during co-cultivation of mast cells and bacteria, could not be 
elucidated. These factor(s) could potentially be identified by analysing media 
conditioned with both S. aureus and mast cells using mass spectrometry. VEGF 
is involved in tumour angiogenesis. Several species of bacteria are known to 
infiltrate and colonise tumours. Likewise, mast cells frequently populate 
tumours. It is thus possible that bacterial stimuli of tumour-populating mast cells 
3 Concluding Remarks & Future 
Perspectives 
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yield the VEGF required for tumour angiogenesis. If a dual cancer-bacterial 
infection in vivo model could be developed, this hypothesis could be investigated 
using strains of tumour-colonising bacteria and mast cell-deficient mice. Prior 
to any such investigation, the upregulation of VEGF in response both to different 
strains of S. aureus and to other species of bacteria would be required to establish 
whether VEGF induction is species specific. 
A similar approach could be used to investigate the role of the mast cell in 
general bacterial infections. In our study, a laboratory strain of S. aureus was 
used and no differences were found between mast cell competent and deficient 
mice. Optimally, by using different strains of S. aureus and different bacterial 
species, as well as different strains of those species, and alternate routes of 
infection, more general conclusions regarding the mast cell in infection could be 
made. Ideally, wildtype strains derived from diseased animals could be used as 
an alternative to the laboratory strains. 
A similar approach was used in our non-mammary mouse mastitis model. 
Mice were infected by intraperitoneal injection with a number of different 
bacterial strains representing two major mastitis pathogen species, E. coli and S. 
aureus. We found that one particular strain of E. coli, strain 127, caused 
consistently more severe infections and generated a distinct cytokine profile 
(CCL2, G-CSF, CXCL1). The concentrations of these cytokines correlated with 
both disease severity and bacterial burden. It is imperative that these strains, and 
potentially additional strains and other species of common mastitis bacterial 
pathogens, are used in further investigations with a bovine model system rather 
than a mouse system. In lieu of an in vivo bovine infection system, which would 
be prohibitively difficult both from a practical and ethical standpoint, a model 
using bovine mammary tissue could be employed. Tissue could be sourced from 
recently slaughtered animals. Though bovine cell lines are available, the bovine 
mammary immune response is likely better modelled using whole tissue rather 
than individual cell types. 
The clinical, immunological and metabolic changes that occur during 
mastitis were studied using a kinetic approach applied to an in vivo LPS-induced 
acute bovine mastitis model. We found that metabolic changes occurred earlier 
in the plasma than in the milk, which was also reflected in the clinical 
parameters, where changes in the general condition occurred earlier than 
changes in the milk. No role for mast cells in mastitis was found with this LPS-
induced model, at least not in a role involving degranulation. An ideal 
continuation of this study would be to use a similar intramammary infusion 
model substituting LPS with live whole bacteria, such as the bacterial strains 
used in our mouse non-mammary infection model. This approach would enable 
the investigation of changes in clinical parameters and molecular and metabolic 
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profiles over time in response to both different species of bacteria and different 
strains. Such a strategy would better reflect the actual changes in bovine 
physiology that operate during mastitis than the response to a purified bacterial 
component. However, as noted previously, such a model would be prohibitively 
difficult to use due to both practical and ethical reasons. An alternative would be 
to infuse cows with inactivated bacteria. Whether any response could be elicited 
to such stimuli could be determined by performing pilot studies using a bovine 
tissue mammary in vitro model similar to the one outlined above. 
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The signs of inflammation are easily recognisable: heat, swelling, redness and 
pain. Inflammation is a broad response of the immune system to exposure to 
trauma or harmful microorganisms such as bacteria. Inflammation damages both 
invading microbes and host tissue alike. This thesis is focused on the 
mechanisms involved in inflammation caused by bacterial infection, in the 
context of mast cells and mastitis. 
The mast cell is a white blood cell, a component of the immune system. These 
cells are found in high numbers in the skin, intestine, lungs and other tissues that 
are directly exposed to the environment. Mast cells store large numbers of pro-
inflammatory compounds (so called ‘mediators’). Such mediators include 
histamine and cytokines (proteins used to signal between cells). These 
substances can be released within seconds of mast cell activation. Mast cells also 
produce mediators in response to activation, which are released over time 
(minutes to hours). Such mediators include antimicrobial peptides (peptide that 
directly kill microbes) and many additional cytokines. Mast cells are believed to 
assist in the response to bacterial infection by, for example, recruiting other 
immune cells to an infected tissue by releasing cytokines. 
Mastitis is an inflammation of the milk-producing tissue in the mammary 
glands of mammals. The inflammation is usually caused by a bacterial infection. 
Mastitis is one of the most economically destructive diseases in the dairy 
industry worldwide. It reduces milk yield and quality and incurs high veterinary 
costs. 
Mast cell responses to live bacteria were studied by culturing them together 
(Paper I) or by using a mouse infection model (Paper II). In Paper I, mast cell 
production and the release of vascular endothelial growth factor (VEGF) were 
studied. VEGF is a potent promoter of blood vessel growth (angiogenesis). We 
found that live Staphylococcus aureus (S. aureus) was required to activate the 
release of VEGF from mast cells. Individual purified bacterial components (e.g., 
bacterial cell wall components) did not active mast cells to produce VEGF. Mast 
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cells have long been thought to be involved in angiogenesis due to their ability 
to produce VEGF, but this bacterial induction of VEGF has not been previously 
reported. It could possibly be involved in tumour processes. Both mast cells and 
bacteria have been observed to populate certain tumours. It is possible that 
bacteria promote blood vessel growth in tumours by inducing mast cells to 
produce VEGF. 
In Paper II, using a mouse S. aureus infection model, comparing normal 
wildtype mice with genetically modified mice lacking mast cells, we observed 
that the lack of mast cells did not affect the progress of the infection. This was 
measured by weighing the mice, measuring the clearance of bacteria (how well 
the immune systems of the mice could kill the bacteria), measuring the 
concentrations of pro-inflammatory cytokines and counting the inflammatory 
cells recruited to the infected site. Previous mouse infection studies have used 
mast cell-deficient mice that are dependent on mutations in a receptor called c-
Kit. c-Kit is a receptor for a growth factor that is essential for mast cells. Defects 
in this receptor cause a loss of mast cells. However, because c-Kit is required by 
many other cells, mutations also cause many other defects. It is therefore difficult 
to draw conclusions from these models because the observed effects in the mast 
cell-deficient mice could have been caused by other defects. In contrast, we used 
a new model in which the mast cells were removed using a targeted genetic 
modification independent of the c-Kit receptor (Mcpt5-Cre mice). These mice 
have fewer non-mast cell-related defects.  
 Mastitis was investigated using a live mouse model (Paper III) and a live 
bovine model (Paper IV). In Paper III, the live mouse model was used to study 
the virulence (the ability of a microbe to infect or damage a host) of a selection 
of Escherichia coli (E. coli) and S. aureus strains originally isolated from the 
udders of cows afflicted with acute mastitis. The aim was to assess whether the 
virulence of a strain could be linked to the immune response they provoked. The 
response to infection was judged by a clinical score, by estimating bacterial 
clearance and by measuring the release of cytokines. We found that one strain 
of E. coli (strain 127) caused consistently more severe infections and elicited a 
distinct profile of cytokines (CXCL1, G-CSF, CCL2). We also found that the 
concentration of these cytokines correlated to the clinical score and the extent of 
bacterial clearance. 
In Paper IV, a live bovine mastitis model was used to study the local and 
systemic effects of the inflammatory response over time. Mastitis was provoked 
by infusing lipopolysaccharide (LPS; a bacterial component) into udders. The 
effects on the animals were observed as clinical parameters (signs of 
inflammation in the udder), signs of mastitis in the milk (change in colour and 
appearance of clots), recruitment of immune cells into the milk and release of 
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cytokines into the milk as well as blood. We also measured changes in the levels 
of metabolites in the milk and the blood. Measurement in the blood allowed an 
estimation of the effects in whole animals (systemic). Metabolites are molecules 
that are generated by a living organism’s metabolism. We found that local and 
systemic effects occurred at different time points after LPS infusion. We 
observed that the changes occurred in the following order: (1) signs of 
inflammation in the udder and increases in milk cytokine concentrations (two 
hours), (2) visible changes in the milk and increased numbers of immune cells 
in the milk (four hours), (3) changes in the levels of plasma metabolites (four 
hours) and (4) changes in the levels of milk metabolites (24 hours). 
 
Conclusions: 
➢ Paper I: Mast cell synthesis and release of VEGF required live whole S. 
aureus. 
➢ Paper II: Mast cells do not influence the course of S. aureus infection in 
mice, with regards to weight loss, bacterial clearance, recruitment of immune 
cells and the release of cytokines. 
➢ Paper III: The release of cytokines in response to a highly virulent E. coli 
strain can be correlated to the severity of infection and bacterial clearance in 
a mouse mastitis model. 
➢ Paper IV: Local (udder) and systemic (blood) changes in response to acute 
mastitis occur at different time points after induction of inflammation. 
Changes in the udder occur earlier than the systemic changes. 
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Inflammation är ett ospecifikt immunsvar mot exempelvis invasion av 
sjukdomsalstrande organismer (bakterier, virus, svampar och parasiter). 
Inflammation kännetecknas av svullnad, hetta, smärta och rodnad. 
Immunförsvaret består både av anatomiska barriärer (exempelvis huden) och 
ett antal specialiserade celler (vita blodkroppar) vars funktion är att förhindra 
och bekämpa angrepp av mikroorganismer. Mastcellen är en vit blodkropp som 
återfinns i särskilt stora antal i vävnader som är i direkt kontakt med miljön 
såsom huden, lungor och tarmar. Mastceller lagrar en rad olika substanser som 
har en pro-inflammatorisk effekt på kroppen (så kallade mediatorer). Dessa 
substanser kan mastcellen frisätta som svar på olika slags stimuli. Frisättningen, 
även kallad degranulering, sker inom loppet av sekunder. Mastcellen kan även 
nyproducera substanser som den avger över tid (timmar). Mångårig forskning 
har identifierat mastcellen som en slags ’vaktcell’ mot sjukdomsalstrande 
mikroorganismer. Mastit är en av de mest förlustbringande sjukdomarna inom 
mjölkindustrin. I denna avhandling studerades inflammation i sammanhanget 
bakterieinfektion med särskilt fokus på mastcellen och mastit.  
Det är känt sedan tidigare att mastceller produceras vaskulär 
endotelcelltillväxtfaktor (förkortat VEGF), en tillväxtfaktor inblandad i 
nybildningen av blodkärl (angiogenes). Vi studerade mastcellens produktion av 
VEGF i samband med bakterieinfektion. Detta då en tidigare studie påvisat att 
det genetiska uttrycket av VEGF ökade markant som svar mot stimulans med 
Staphylococcus aureus (S. aureus; en vanlig bakterieart). Vi studerade detta 
tidigare okända samband närmare genom att odla mastceller och levande S. 
aureus under olika odlingsförhållanden. Vi stimulerade även mastceller med 
renade bakteriekomponenteter. Vi fann att uttrycket av VEGF i mastceller var 
beroende av närvaron av levande hela bakterier, då inaktiverade bakterier och 
enskilda bakteriekomponenter inte aktiverade mastcellens produktion av VEGF 
(Artikel I).  
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Mastcellens roll i bakterieinfektion studerades med en levande musmodell. 
Många tidigare studier inom detta område har använt sig av så kallade c-Kit 
beroende mastcellsdefekta möss. Tillväxtfaktorn stamcellfaktor (förkortat SCF) 
är vital för utvecklingen av mastceller. Omogna mastceller binder till sig SCF 
genom en receptor kallad c-Kit. I c-Kit beroende mastcellsdefekta möss är 
receptorn c-Kit muterad. Mutationen innebär att den inte kan binda till SCF. 
Konsekvensen är att dessa möss inte kan bilda några mastceller (det vill säga, 
”mastcellsdefekta”). Problemet med dessa möss är att c-Kit även är en viktig 
receptor för många andra celler. Vid sidan av bristen på mastceller lider dessa 
möss även av andra defekter, något som kan påverka resultaten som dessa möss 
ger i studier. Vi använde oss av en ny mastcellsdefekt musmodell där frånvaron 
av mastceller inte är beroende av mutationer i c-Kit, så kallade Mcpt5-Cre+ x R-
DTA möss. Olikt många tidigare studier, där c-Kit muterade möss använts, fann 
vi att mastcellen inte spelade någon roll i immunsvaret mot S. aureus infektion 
av bukhålan. Vi såg inga skillnad mellan de mastcellsdefekta mössen och de 
normala kontrollmössen. Mössens viktförändring, deras immunförsvars förmåga 
att döda bakterier (”clearance”), rekrytering av vita blodkroppar och produktion 
av cytokiner (signalmolekyler viktiga för immunförsvaret) studerades (Artikel 
II). 
Med en musmodell studerade vi hur immunsvaret varierade mot olika 
stammar av ett par vanliga mastit orsakande bakterier, Escherichia coli (E. coli) 
och S. aureus. Olika stammar av samma art kan ha olika förmåga att orsaka 
sjukdomar. Urvalet av stammar i denna studie isolerades ursprungligen från kor 
med akut klinisk mastit. Med denna musmodell fann vi att en av E. coli 
stammarna – stam 127 – orsakade allvarligare infektioner än de övriga 
stammarna. Immunsvaret mot denna stam ledde även till en distinkt profil av 
cytokiner som korrelerade med sjukdomstillståndet (det vill säga, högre mängd 
cytokin utvecklades i mer sjuka djur). Dessa resultat skulle kunna följas upp i en 
komodell, exempelvis i en modell där juvervävnad från slaktade djur stimuleras 
med bakterier (Artikel III). 
Vi studerade förloppet av akut klinisk mastit med en levande komodell, där 
mastit framkallades med en juverinfusion av E. coli endotoxin. 
Sjukdomsförloppet studerades i termer av kliniska förändringar (bedömdes med 
en klinisk score och mjölkförändringar), förändringar av mängden cytokiner i 
mjölk och blod, samt förändringar i koncentrationen av metaboliter i mjölk och 
blod. Metaboliter är molekyler som genereras av en levande organisms 
metabolism. Sjukdomsförloppet följdes över tid. Vi fann att dessa förändringar 
skedde i en specifik ordning: (1) tecken på inflammation i juvret och förhöjd 
mängd cytokiner i mjölken (två timmar), (2) synliga förändringar i mjölken och 
förhöjda somatiska cellantal i mjölken (SCCs) (fyra timmar), (3) förändringar i 
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mängden metaboliter i blodet (fyra timmar) och (4) förändringar i mängden 
metaboliter i mjölken (24 timmar) (Artikel IV). 
 
Slutsatser: 
➢ Artikel I: Uttryck av VEGF i mastcellen krävde stimuli med levande S. 
aureus. 
➢ Artikel II: Mastcellen påverkar inte förloppet av S. aureus infektion i möss 
med avseende på viktförlust, ”clearance”, rekrytering av vita blodkroppar 
och frisättningen av cytokiner. 
➢ Artikel III: Frisättningen av cytokiner som sker som svar mot en hög 
virulent E. coli stam korrelerade mot graden infektion och ”clearance” i en 
musmodell av mastit. 
➢ Artikel IV: Lokala och systemiska förändringar under akut mastit sker vid 
olika tidpunkter efter infusion med endotoxin. 
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